US Patent no. 8,728,553 adds cardiovascular health to an earlier patent (no. 8,354,129), which covered inclusion of vitamin K2 in a food product at a range of 50 to 5,000 micrograms per 100 g of product.
“The new patent provides NattoPharma a patented exclusive right to tell users of vitamin K2 that supplements and foods containing 5 to 5,000 micrograms of vitamin K2 per 100 grams of product have positive health effects,” said NattoPharma CEO Hogne Vik.
“While we have only had ‘exclusive rights’ for such claims for amounts from 5 to 200 mcg of vitamin K2 per 100 grams of product, almost every vitamin K2-enriched food product and dietary supplement in the United States will be covered by NattoPharma’s patent continuation, which gives us a unique market position.”
“The approval of the patent is an important milestone for NattoPharma and our partners in the United States, as it will further strengthen NattoPharma's global patent platform and the competitive position in the United States.”